GLP-1 Peptide Drugs Are Now Preconception Drugs, Whether We Planned It or Not
GLP-1 drugs are common in reproductive-age women. The real risks before pregnancy are not the ones that make people panic. Three numbers matter: the washout, the pill interaction, and the rebound.
Peptides in Women’s Health · Part 4 of 7
The most urgent peptide issue in obstetrics now, reduced to three numbers every woman on a GLP-1 should know.
Millions of women of reproductive age now take a GLP-1 drug. That makes semaglutide and tirzepatide preconception drugs, whether obstetrics planned for it or not. And the real risks around pregnancy are not the ones that make people panic.
GLP-1 drugs are not recommended during pregnancy. Animal studies suggest possible harm, and human data are still limited. So the standard advice is to stop before trying to conceive. The drug labels build in a washout window because these medications stay in the body for weeks. The catch is that fertility can return as weight drops, sometimes before a woman expects it.
Three numbers decide how this goes, and most women never hear them: how long before conception to stop the drug, whether the drug weakens the pill, and what happens to the pregnancy if the drug is stopped abruptly at the wrong moment. Get those three right and the picture is reassuring. Miss them and the avoidable problems show up.
Paid subscribers continue below.
